![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07H 19/10 | (2006.01) |
C07F 9/24 | (2013.01) | ||
C07H 1/00 | (2006.01) | ||
C07H 1/02 | (2013.01) | ||
C07F 9/24 | (2006.01) | ||
C07H 19/10 | (2013.01) | ||
C07H 1/02 | (2006.01) | ||
A61P 35/00 | (2018.01) |
(11) | Patento numeris | 3351551 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16845696.0 |
Europos patento paraiškos padavimo data | 2016-09-13 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-07-25 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-12-07 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/CN2016/098846 |
Data | 2016-09-13 |
(87) | Numeris | WO 2017/045582 |
Data | 2017-03-23 |
(30) | Numeris | Data | Šalis |
201510588122 | 2015-09-16 | CN |
(72) |
YUAN, Jiandong , CN
HUANG, Yangqing , CN
MIAO, Linfeng , CN
GU, Jianing , CN
LIANG, Chaohua , CN
WANG, Zhengye , CN
SUN, Zhanli , CN
|
(73) |
BrightGene Bio-Medical Technology Co., Ltd. ,
Building C25
No. 218 Xinghu Street, BioBay, Suzhou Industrial Park
Suzhou Jiangsu 215123,
CN
|
(54) | PREPARATION METHOD OF NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS AND INTERMEDIATES THEREOF |
PREPARATION METHOD OF NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS AND INTERMEDIATES THEREOF |